Question

develop three medication cart for mental health including side effect, drug type, indication, nursing consideration

Answer 1

Drug Name	Class	Indication	Side- Effect	Nursing Considerations
Fluoxetine	Anti-depressants	Treatment of depression; most effective in patients with major depressive disorder Treatment of OCD Treatment of bulimia Treatment of PMDD (Sarafem) Treatment of panic disorder with or without agoraphobia Unlabeled use: Treatment of obesity, alcoholism, numerous psychiatric disorders, chronic pain, various neuropathies	More common Hives, itching, or skin rash inability to sit still restlessness Less common Chills or fever joint or muscle pain Rare Anxiety cold sweats confusion convulsions (seizures) cool pale skin diarrhea difficulty with concentration drowsiness dryness of the mouth excessive hunger fast or irregular heartbeat headache increased sweating increased thirst	Arrange for lower or less frequent doses in elderly patients and patients with hepatic or renal impairment. Administer drug in the morning. Monitor patient for response to therapy for up to 4 wk before increasing dose. Switch to once a week therapy by starting weekly dose 7 days after last 20 mg/day dose. If response is not satisfactory, reconsider daily dosing.
Olanzapine	Anti-Psychotics	Schizophrenia Bipolar Disorder-I (Maniac Episodes)	an inability to sit still (akathisia), constipation, dizziness, drowsiness, insomnia, dry mouth, orthostatic hypotension, tremor, and weight gain.	Do not dispense more than 1-wk supply at a time. Peel back foil on blister pack of disintegrating tablets; do not push through foil; use dry hands to remove tablet and place in mouth. Monitor for the many possible drug interactions before beginning therapy.
Lithium Carbonate	Anti-Maniacs	Acute Mania To decrease Suicidal Tendancy	Exacerbation of psoriasis acne rash nausea diarrhoea, vertigo, muscle weakness dazed feeling; loss of concentration tremors hypothyroidism; weight gain edema cardiac arrhythmias exophthalmos; restlessness Electrolyte disturbances Potentially Fatal: Severe neurotoxicity, leucopenia.	Give with caution and daily monitoring of serum lithium levels to patients with renal or CV disease, debilitation, or dehydration or life-threatening psychiatric disorders. Give drug with food or milk or after meals. Monitor clinical status closely, especially during initial stages of therapy; monitor for therapeutic serum levels of 0.6–1.2 mEq/L; toxicity is closely related to serum levels. Individuals vary in their reponse to this drug; some patients may exhibit toxic signs at serum lithium levels considered within the therapeutic range. Advise patient that this drug may cause serious fetal harm and cannot be used during pregnancy; urge use of barrier contraceptives. Decrease dosage after the acute manic episode is controlled; lithium tolerance is greater during the acute manic phase and decreases when manic symptoms subside. Ensure that patient maintains adequate intake of salt and adequate intake of fluid (2,500–3,000 mL/day).